Results for 'communicating with patient advocates'





The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
Jan 24th • 12 mins read

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
Mar 25th • 10 mins read

Improving Transparency in Phase 1 Clinical Trials
Feb 9th • 29 mins read

Barriers to Clinical Trial Participation for Transgender People
Apr 25th • 26 mins read

New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
Mar 21st • 16 mins read

Addressing the Impact of Prior Authorization on Access to Cancer Treatment
Jun 8th • 26 mins read

How AI Can Improve Patient Identification and Recruitment for Clinical Trials
Aug 15th • 19 mins read

Biosimilars 2019 | Interview with Sanjiv S Agarwala, MD
Apr 15th • 29 mins read

Biosimilars 2019 | Interview with Gary H Lyman, MD, MPH
Apr 15th • 49 mins read

Biosimilars 2019 | Interview with Hope S Rugo, MD
Apr 15th • 26 mins read

Recent Advances and Future Directions in Oncology
Nov 23rd • 364 mins read

Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas
Mar 4th • 60 mins read

What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hodgkin and Non-Hodgkin Lymphomas
Jul 22nd • 62 mins read

Recent Advances and Real-World Implications in Multiple Myeloma
Mar 4th • 60 mins read

Industry Challenges Contribute to Financial Toxicity
Feb 18th • 66 mins read

How Washington Is Tackling High Prescription Drug Costs
Feb 16th • 32 mins read